Book Value per Share: Singular Genomics (OMIC)

Graphic logo of Singular Genomics Systems (OMIC)

Complex patents and stringent FDA controls create a powerful defensive barrier for Singular Genomics Systems (OMIC), although a narrow specialization in NGS systems triggers a search for mergers. The book value per share demonstrates the current capitalization vector, where the 48.76 mark reflects the latest data. Business stability is ensured by the innovative G4 platform, which accelerates the acquisition of genetic data in US laboratories.

Singular Genomics Systems Inc (OMIC) Equity per Share: for the period 07/04/2022 - 03/01/2025

singulargenomics.com - analytical breakdowns and key metrics (OMIC)

- price and consensus price forecast:
Stock Price Singular Genomics Systems Inc|OMIC - Analyst Median Target
- market capitalization data:
Market Capitalization Singular Genomics Systems|OMIC - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share Singular Genomics|OMIC - Accounting Capitalization|Market Value to Book Value Ratio singulargenomics.com|OMIC - Total Business Assets
- debt and liquidity data:
Total Debt to Capital Singular Genomics Systems|OMIC - Long-Term Debt to Capital|Short-Term Debt to Equity Singular Genomics|OMIC - Company Total Debt Obligations|Debts to Book Capitalization Singular Genomics Systems
Analysis of all company metrics:Singular Genomics Systems Inc OMIC
Manufactured products of Singular Genomics

Book value per share determines the issuer's net assets, excluding market fluctuations, and demonstrates the real asset base of the business. By analyzing the book value per common share indicator on GURU.Markets, an investor assesses the capitalization of Singular Genomics Systems (OMIC) through the lens of its sequencing technology value, where the stability of this metric confirms the resource base for the G4 platform to compete with industry behemoths.

Competitor analysis for Singular Genomics Systems

Book Value per Share TEM (Tempus AI, Inc.)|QGEN - Net Assets per Share|IONS (Ionis Pharmaceuticals) - Book Value per Share|repligen.com (RGEN) - Accounting Value per Share|Book Value per Share Avidity Biosciences, Inc. (RNA)|Equity per Share CRSP|Net Assets per Single Share Sema4 WGS|Equity per Share Ultragenyx Corp (RARE)|Book Value per Share BEAM (Beam Therapeutics Inc.)|sarepta.com - Book Value per Share|Net Assets per Single Share TWST (Twist Bioscience, Inc.)|TXG - Net Assets per Share|Intellia - Book Value per Share|STOK (Stoke Corp) - Net Assets per Share|Net Assets per Single Share BioLife Solutions, Inc. (BLFS)|Equity per Share wavelifesciences.com|MAZE: Book Value per Share|Book Value of One Share Sionna Therapeutics, Inc. SION|Accounting Value per Share PRME (Prime Medicine Corp)|Taysha Corp - Book Value per Share|QURE - Net Assets per Single Share|MGTX - Net Assets per Single Share|RGNX: Book Value per Share|SLDB (Solid Biosciences Inc) - Book Value per Share|OCGN - Net Assets per Single Share|Accounting Value of a Share PacBio Corp (PACB)|Benitec Biopharma Inc. (BNTC) - Accounting Value per Share|Accounting Value of a Share designtx.com (DSGN)|RCKT (Rocket Pharmaceuticals, Inc.) - Book Value per Share|Book Value of One Share 4DMT FDMT|LXEO (Lexeo) - Book Value per Share|KRRO: Net Asset Value per Share|Net Assets per Single Share Editas Medicine, Inc.|SLN (silence-therapeutics.com) - Equity per Share|Net Assets per Single Share PRQR (ProQR)|Net Asset Value per Share CDXS|Net Assets per Single Share SGMO (Sangamo)|Accounting Value per Share nautilus.bio (NAUT)|Book Value per Share MGX|Net Assets per Share Precision BioSciences Inc. DTIL|GBIO: Book Value per Share|BOLD: Accounting Value per Share|exicuretx.com - Net Assets per Single Share|Net Assets per Share Imunon|PHIO - Accounting Value per Share|Accounting Value of a Share MBIO|RNAZ (TransCode Therapeutics) - Net Assets per Single Share|Net Assets per Share bionanogenomics.com BNGO|APDN: Accounting Value per Share|bluebird bio, Inc - Net Asset Value per Share|Net Assets per Single Share IPA (ImmunoPrecise)|omegatherapeutics.com (OMGA) - Net Assets per Share|RGLS - Accounting Value per Share|Syros Pharmaceuticals Inc. (SYRS) - Book Price of a Share|Book Value per Share TBIO (Codex DNA)|Net Asset Value per Share TCON|Net Assets per Single Share UBX (Unity Biotechnology)